article_metadata: Marlene Plüß Kemal Mese Johannes T Kowallick Andreas Schuster Désirée Tampe Björn Tampe
article_metadata: 10.3389/fimmu.2021.784145
article_metadata: Front Immunol
article_metadata: 2022 Jan 18;12:784145.
article_metadata: chadox1 ncov-19 sars-cov-2 vaccination cytomegalovirus long covid viral reactivation
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/35116025/
article_metadata: ChAdOx1 nCoV-19 / adverse effects Cytomegalovirus / drug effects Pericarditis / chemically induced SARS-CoV-2 / immunology Virus Activation / drug effects
article_metadata: ChAdOx1 nCoV-19 / adverse effects Cytomegalovirus / drug effects Pericarditis / chemically induced SARS-CoV-2 / immunology Virus Activation / drug effects Case Reports Aged Antiviral Agents / therapeutic use COVID-19 / prevention & control Cytomegalovirus / physiology Cytomegalovirus Infections / chemically induced Cytomegalovirus Infections / drug therapy Cytomegalovirus Infections / virology Female Humans Pericarditis / drug therapy Pericarditis / virology Treatment Outcome Valganciclovir / therapeutic use Viremia / chemically induced Viremia / drug therapy Viremia / virology Antiviral Agents ChAdOx1 nCoV-19 Valganciclovir
article_metadata: PMC8803643
article_metadata: 35116025
article_metadata: Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
article_metadata: 2022